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Developmental timing genes catalyze stem cell pro-
gression and animal maturation programs across
taxa. Caenorhabditis elegans DRE-1/FBXO11 func-
tions inanSCFE3-ubiquitin ligasecomplex to regulate
the transition to adult programs, but its cognate pro-
teolytic substrates are unknown. Here, we identify
the conserved transcription factor BLMP-1 as a
substrate of the SCFDRE-1/FBXO11 complex. blmp-1
deletion suppressed dre-1 mutant phenotypes and
exhibited developmental timing defects opposite to
dre-1. blmp-1 also opposed dre-1 for other life history
traits, including entry into the dauer diapause and
longevity. BLMP-1 protein was strikingly elevated
upon dre-1 depletion and dysregulated in a stage-
and tissue-specific manner. The role of DRE-1 in
regulatingBLMP-1stability isevolutionary conserved,
as we observed direct protein interaction and
degradation function for worm and human counter-
parts. Taken together, posttranslational regulation
of BLMP-1/BLIMP-1 by DRE-1/FBXO11 coordinates
C. elegans developmental timing and other life history
traits, suggesting that this two-protein module medi-
ates metazoan maturation processes.
INTRODUCTION
All metazoans develop via successive life stages and mature to
reproductive adults. At the cellular level, temporal and positional
fatesmust be precisely regulated to ensure coordination of prolif-
erative,morphogenetic, anddifferentiationevents. The nematode
Caenorhabditis elegans develops from embryo, through four
larval stages, to reach reproductive maturity. Each larval stage
is marked by ecdysis and characterized by virtually invariant pat-
terns of stage-specific cellular events (Sulston andHorvitz, 1977).DeveloTemporal selectors called heterochronic genes orchestrate
temporal cellular fates during C. elegans larval development
across tissues (Ambros and Horvitz, 1984). Mutations in the het-
erochronic loci result in precocious or retarded expression of
stage-specific cellular events, which often manifest as a deletion
or repetition of such programs. There are over 30 identified het-
erochronic loci, which encode various transcriptional, transla-
tional, and posttranslational regulators (Resnick et al., 2010).
Importantly, most heterochronic genes are highly conserved
and have emerged as crucial regulators of proliferation, differen-
tiation, and stem cell dynamics in mammals (Rybak et al., 2009;
Yu et al., 2007). For example, the RNA binding protein LIN28 has
been implicated in precocious puberty in humans (Park et al.,
2012), revealing remarkable conservation of function from the
molecular to the organismal level.
C. elegans dre-1 was isolated in an enhancer screen for DAF-
12/FXR/VDR-redundant functions in gonadal heterochrony, as
the double mutant gives rise to a synthetic gonadal migration
defect in which the gonadal arms fail to turn on schedule (Fielen-
bach et al., 2007). On their own, dre-1 hypomorphic mutants also
display heterochronic phenotypes in epidermal stem cells, called
seams, causing precocious seam cell fusion and terminal differ-
entiation a full stage earlier than normal (Fielenbach et al., 2007).
dre-1 null mutants arrest after hatching or in the L1 stage often
displaying molting defects.
F box proteins function as the substrate-recognition compo-
nents of SKP1-CUL1-F box (SCF) E3-ubiquitin ligase complexes,
thus conferring substrate specificity to the ubiquitin-proteasome
system (UPS) (Skaar et al., 2013). C. elegans DRE-1 and its
mammalian homolog FBXO11 are F box proteins and have previ-
ously been shown to work in an SCF complex (Duan et al., 2012;
Fielenbach et al., 2007). Interestingly, DRE-1/FBXO11 is one of
only about ten F box proteins highly conserved across all major
taxa (Shaye and Greenwald, 2011).
In mice, homozygousmutation of Fbxo11 results in facial cleft-
ing and perinatal lethality, as observed in Mutt and Jeff mutant
mice, which were identified in ENU mutagenesis screens. More-
over, in mice and humans, Fbxo11 haploinsufficiency is linked
to the onset of otitis media, an inflammation of the middle earpmental Cell 28, 697–710, March 31, 2014 ª2014 Elsevier Inc. 697
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DRE-1 Targets BLMP-1 for Degradationaffecting children (Hardisty et al., 2003; Hardisty-Hughes et al.,
2006; Segade et al., 2006). Two substrates of human FBXO11,
BCL6 and CDT2, which promote lymphoma formation and delay
cell-cycle exit, respectively, have recently been identified (Abbas
et al., 2013; Duan et al., 2012; Rossi et al., 2013). However,
the substrates mediating developmental timing alterations in
dre-1/Fbxo11 mutants have remained largely elusive.
To elucidate the mechanism of posttranslational control of
developmental timing by DRE-1/FBXO11, we sought to identify
proteolytic targets by performing genetic suppressor screens
in C. elegans. We discovered that the highly conserved zinc-
finger transcriptional repressor BLMP-1/BLIMP-1 is regulated
by the SCFDRE-1/FBXO11 complex via proteasome-dependent
degradation. Our studies reveal that blmp-1 is a heterochronic
gene, whose misregulation accounts for most developmental
alterations observed in dre-1 mutants and demonstrate that
DRE-1-dependent BLMP-1 regulation is conserved across taxa.
RESULTS
blmp-1 and nhr-25 Suppress dre-1 Epidermal
Heterochrony
Because DRE-1/FBXO11 acts as the substrate-recognition
component of an SCF E3-ubiquitin ligase complex, we reasoned
that dre-1 loss of function would lead to aberrant accumulation of
client substrates. If so, thenknockdownof such substrates should
suppress the developmental timing defects seen in dre-1 mu-
tants.We thereforeperformedanRNAi-basedsuppressorscreen,
looking for amelioration of developmental timing defects in partial
loss-of-function dre-1(dh99) mutants. We focused our screen
initially on transcription factors as well as known heterochronic
loci as candidates. We identified the zinc-finger transcription
factor blmp-1 as a potent suppressor of dre-1 heterochronic phe-
notypes. The predicted C. elegans BLMP-1 protein harbors an
N-terminal SET domain, a proline-rich domain, and five paired-
domain zinc fingers at the C terminus. An existing deletion allele
tm548 lacks part of exon 3 and results in a frameshift that disrupts
the SET domain and all subsequent zinc fingers, suggesting it is a
null allele. Mammalian BLIMP-1 is the major B-lymphocyte matu-
ration factorbut alsogovernsvariouscell-fatedecisions, including
primordial germ cell specification and skin differentiation, gener-
ally working as a transcriptional repressor (Horsley et al., 2006;
Ohinata et al., 2005; Turner et al., 1994). Importantly, C. elegans
BLMP-1 and mammalian BLIMP-1 show high domain conserva-
tion, with 43% similarity in the SET domain and 70% similarity in
the zinc fingers (Tunyaplin et al., 2000).
blmp-1 loss of function suppressed dre-1 phenotypes in multi-
ple tissues, including epidermis and gonad. During normal termi-
nal differentiation of the hypodermis, epidermal seam cells exit
the cell cycle early in the L4 larval stage, fuse, and then synthe-
size a continuous ridged cuticular structure called adult alae
(Figure 1A). In dre-1 partial loss-of-function mutants (e.g., dre-
1(dh99)) seam cells undergo precocious terminal differentiation
in L3, a full stage ahead of schedule (Fielenbach et al., 2007) (Fig-
ures 1A–1C). Using the adherens junction marker ajm-1:gfp to
mark seamcell boundaries,weobserved thatblmp-1 knockdown
by RNAi reduced dre-1(dh99) precocious seam cell fusion from
90% to 15% of the animals (Figures 1B and 1C). Similarly only
7.5% of dre-1;blmp-1(tm548) double mutant animals showed698 Developmental Cell 28, 697–710, March 31, 2014 ª2014 Elsevierseamcell fusion in L3 (Figure 1C). Notably,blmp-1mutants them-
selves displayed heterochronic phenotypes: although blmp-1
mutants had normal timing for seam cell division and fusion
(Table S1 available online), they exhibited incomplete adult alae
synthesis, a phenotype typical of weakly retarded mutants (Fig-
ures 1D and 1E). Incomplete alae formationwas rescued by intro-
ducing a fosmid-based blmp-1::gfp translational fusion construct
(Figure 1E), demonstrating that the phenotype arises from lesions
in blmp-1. Moreover, in dre-1;blmp-1 doublemutants, the incom-
plete alae formation phenotype of blmp-1 prevailed, placing
blmp-1 genetically downstream (Figures 1A and 1E). Thus,
blmp-1 and dre-1 have opposite phenotypes in the seams, and
dre-1 phenotypes depend on functional blmp-1(+).
Another transcription factor identified in our screen was the
homolog of mammalian steroidogenic-factor-1, called nhr-25,
a nuclear hormone receptor implicated in C. elegans molting
and epidermal developmental timing (Gissendanner and Sluder,
2000; Hada et al., 2010; Silha´nkova´ et al., 2005). Notably, nhr-25
depletion reportedly induces retarded seam cell fusion and
prevents precocious adult alae formation (Hada et al., 2010).
We observed that nhr-25 depletion also significantly suppressed
dre-1 precocious seam cell fusion from 90% to 21.5% of the
animals (Figure 1C). Thus, complete terminal differentiation of
C. elegans epidermal stem cells depends on both blmp-1 and
nhr-25.
blmp-1 Suppresses dre-1 Gonadal Heterochrony
We next asked whether blmp-1 and nhr-25 also influenced dre-1
developmental timing phenotypes in the gonad. In hermaph-
rodites, gonadal morphogenesis is led by two distal tip cells
(dtcs), whichmigrate frommidbody in opposite directions toward
head and tail during L2. In L3, dtcs reflex dorsally and centripe-
tally back toward the midbody to form two U-shaped gonadal
arms in adult animals (Figure 2A).Whereas dre-1mutants on their
own show only a weakly retarded gonadal migration phenotype,
combinations with other heterochronic loci, such as daf-12/FXR/
VDR or the lin-29/EGR null mutants, unveil a strongly synthetic
retarded phenotype in which both gonadal arms fail to reflex
(Figures 2A–2C) (Fielenbach et al., 2007). The unreflexed gonadal
phenotype is interpreted as a reiteration of L2-programs, with
concomitant prevention of L3-specific gonadal events.
Strikingly, depletion of blmp-1 suppressed the strongly
retarded phenotype of dre-1(dh99);daf-12(rh61rh411) mutants,
restoring the dorsal turn inmore than 80%of the animals (Figures
2B and 2C). In contrast, nhr-25 knockdown failed to suppress
the gonadal migration defect (Figure 2C). blmp-1 depletion also
restored gonadal reflection in dre-1;lin-29(n546) mutants,
whereas gonadal migration defects in daf-12;lin-29 remained un-
affected (Figure 2C). These observations reveal that blmp-1 spe-
cifically suppresses gonadal heterochronic phenotypes arising
from dre-1mutation, and not daf-12 or lin-29mutation, suggest-
ing that dre-1 and blmp-1 work in a unified pathway. Consistent
with a role in gonadal developmental timing, blmp-1 mutants on
their own showed precocious gonadal migration defects; dtcs
navigated thefirst turndorsally 2–3hr aheadof schedule but often
failed the second turn and continued migration toward head and
tail (Figures 2A, 2D, and 2E). These phenotypes were rescued by
the full-length blmp-1::gfp transgene (Figure 2E). Notably, the
early gonadal migration defect prevailed in dre-1;daf-12mutantsInc.
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Figure 1. blmp-1 Promotes Terminal Differentiation in the Hypodermis
(A) Seam cell lineages from WT worms and various mutants as inferred from inspection. Terminal differentiation is indicated by fusion of the seams (eye-shaped
cells) and adult alae formation (three horizontal bars). dre-1mutants exhibit precocious seam cell terminal differentiation, whereas blmp-1 and the doublemutants
show incomplete formation of adult alae (three dashed horizontal bars).
(B) Representative images of seam cell adherence junctions as visualized by ajm-1::gfp in WT and dre-1 L3 larvae grown on L4440 empty vector control or blmp-1
RNAi, respectively. Arrowheads indicate seam-seam boundaries.
(C) blmp-1 and nhr-25 RNAi suppress dre-1 precocious seam cell fusion in L3 larvae. ***p < 0.001 (Fisher’s exact test). Mean + 95% CI (n > 30).
(D) Representative DIC images of young adult WT and blmp-1 mutant worms. Arrowheads indicate seam cell positions.
(E) blmp-1 and dre-1;blmp-1 mutants show poor formation of adult alae. The blmp-1 mutant phenotype is rescued by a blmp-1::gfp transgene (n > 20).
Scale bars, 10 mm (B and D).
See also Table S1.
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DRE-1 Targets BLMP-1 for Degradationgrown on blmp-1 RNAi (Figures 2A and 2E), consistent with
blmp-1 acting downstream of dre-1. Taken together, these
results show that dre-1/blmp-1 also function together to coordi-
nate temporal patterning of gonadal outgrowth. Becauseblmp-1,
andnotnhr-25, suppresseddre-1phenotypes inmultiple tissues,
we focused our further analyses on blmp-1.
blmp-1Works Late in the Heterochronic Circuit
To further elucidate the role of blmp-1 in the seam cell hetero-
chronic circuit, we first performed genetic epistasis experimentsDevelowith precocious heterochronic loci that work at the larval-to-
adult switch. Among them, hbl-1/Hunchback, lin-42/Period, lin-
41/Trim71, and sop-2/PolycombG-like specify L4 programs by
preventing lin-29/EGR expression and thus the adult fate (Abra-
hante et al., 2003; Cai et al., 2008; Rougvie and Ambros, 1995;
Slack et al., 2000; Tennessen et al., 2006). Loss-of-function
mutants typically show impenetrant precocious terminal differ-
entiation, in which seam cells fuse and synthesize adult alae
precociously in L3 larvae. Knockdown of blmp-1 variously sup-
pressed precocious seam cell phenotypes of these mutants,pmental Cell 28, 697–710, March 31, 2014 ª2014 Elsevier Inc. 699
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Figure 2. blmp-1 Impedes Dorsal Migration of the Gonad
(A)Schematic representationofgonadalmigrationprogramsofWTwormsandvariousmutantsas inferred from inspection.Arrowheads indicatepositionsof thedtcs.
(B) Representative DIC images of WT and dre-1;daf-12 young adult worms grown on L4440 empty vector control or blmp-1 RNAi, respectively, showing one
gonadal arm. Arrowheads indicate the position of the dtc. v, vulva.
(C) blmp-1 depletion specifically suppresses gonadal migration defects of dre-1;daf-12 and dre-1;lin-29(n546)mutants. ***p < 0.001 (ANOVA). Mean + SEM (n = 3,
40 gonadal arms each).
(D) Representative DIC images of 27 hr posthatching WT and blmp-1mutant larvae staged by the vulval precursor cells (arrowheads, upper panel). Dtcs migrate
precociously in the blmp-1 mutant (arrowheads, lower panel).
(E) dtcs turn dorsally ahead of time in blmp-1 mutants, as well as in WT and dre-1;daf-12 mutants, grown on blmp-1 RNAi. ***p < 0.001 (ANOVA). Mean ± SD.
ns, not significant; nd, not determined. Scale bars, 10 mm (B and D).
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DRE-1 Targets BLMP-1 for Degradationsuggesting it acts downstream or parallel to these components
(Figures 3A–3C; Figure S1A). In particular, blmp-1-retarded
phenotypes (incomplete alae formation) largely prevailed over
hbl-1(ve18), lin-42(n1089), and lin-41i precocious phenotypes,
possibly closely linking these genes in a pathway (Figures 3A,700 Developmental Cell 28, 697–710, March 31, 2014 ª2014 Elsevier3C, and S1A). By comparison, suppression of hypomorphic
sop-2(bx91) phenotypes was relatively weak, suggesting
blmp-1 might work upstream or in parallel to sop-2 (Figure 3A).
We interpret these interactions with caution, because not all
alleles used were null.Inc.
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Figure 3. blmp-1 Interacts with Precocious and Retarded Heterochronic Loci
(A) Epistasis and synergy experiments of blmp-1(tm548)/blmp-1i with precocious (hbl-1(ve18), lin-41i, lin-42(n1089), and sop-2(bx91)) and retarded
(let-7(n2853ts), lin-29(n546), andmab-10(e1248)) heterochronic loci (n > 20). L4440 empty vector functions as control. Partial seam fusion refers to an incomplete
seam syncytiumwith remaining unfused seam cells. Partial alae formation refers to poorly formed or incomplete adult alae. Temperature-sensitive alleles of sop-2
and let-7 were observed after shifting L1 larvae from 15C to 23C or 20C, respectively.
(B) Representative pictures of seam cell adherence junctions as visualized by ajm-1::gfp in hbl-1 and lin-42 L3 larvae grown on L4440 empty vector control or
blmp-1 RNAi, respectively. Arrowheads indicate seam-seam boundaries.
(C) Representative DIC images of hbl-1 and let-7mutants showing adult alae formation under control (L4440) and blmp-1 depleted conditions at the early L4 or
young adult (yA) stage. Arrowheads indicate positions of the seams.
Scale bars, 10 mm (B and C). See also Figure S1.
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DRE-1 Targets BLMP-1 for DegradationWe next examined genetic interactions for synergy with
various retarded heterochronic mutants working at the larval-
to-adult transition. At this transition hbl-1 and lin-41 are downre-
gulated posttranscriptionally by let-7/let-7-family microRNAs
(Abbott et al., 2005; Abrahante et al., 2003; Slack et al., 2000).
Consequentially, lin-29/EGR is derepressed and triggers adult-
specific cell fates. Thus, let-7 and lin-29 loss of function cause
retarded phenotypes: let-7 mutants display incomplete seam
cell fusion and poor or no adult alae; in lin-29 mutants, both
events fail entirely. RNAi-mediated knockdown of blmp-1 in tem-
perature-sensitive let-7(n2853ts) mutants slightly enhanced the
let-7-retarded adult alae formation and the bursting phenotype
at a semi-permissive temperature (Figures 3A and 3C; data not
shown). No enhancement was detected for lin-29(n546) as its
retarded phenotypes are fully penetrant (Figures 3A and S1B).
The transcriptional cofactor mab-10/NAB cooperates with lin-
29/EGR to specify the adult seam fate. Loss-of-function muta-
tions of mab-10 do not affect seam cell fusion and adult alae
formation, but subsets of seam cells undergo an extra nuclear
division after they fuse into the seam syncytium (Harris andDeveloHorvitz, 2011). blmp-1 depletion enhanced the penetrance of
the extra nuclear division phenotype of mab-10(e1248) (Fig-
ure S1C) and worms rarely formed adult alae (Figures 3A and
S1B), suggesting that blmp-1 acts downstream or in parallel
to mab-10. Altogether, these analyses reveal a broad role for
blmp-1 as a developmental timing gene, promoting many
aspects of seam cell terminal differentiation.
dre-1/blmp-1 Regulate the Life History of C. elegans
The interactions described above reveal that dre-1 and blmp-1
act in opposition for developmental timing events. We wondered
whether this relationship also applied to other processes. Inter-
estingly, we found that blmp-1 and dre-1 both function to regu-
late entry into the long-lived dauer stage, an alternate third larval
stage triggered under harsh environmental conditions and food
scarcity. In particular, blmp-1 mutants were defective in dauer
formation (Daf-d), whereas dre-1 mutants constitutively formed
dauer larvae (Daf-c) albeit at low levels, suggesting the
two genes normally promote and prevent dauer formation,
respectively (Figure 4A). Consistent with our previous data, thepmental Cell 28, 697–710, March 31, 2014 ª2014 Elsevier Inc. 701
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Figure 4. dre-1 and blmp-1 Show Oppo-
site Phenotypes in Dauer Formation and
Lifespan
(A) Dauer formation of WT, dre-1(dh99), blmp-
1(tm548), and dre-1(dh99);blmp-1(tm548) animals
scored on plates lacking cholesterol at 27C.
*p < 0.05, ***p < 0.001 (ANOVA). Mean + SEM
(nR 8, >100 worms each).
(B) Dauer formation of WT, daf-2(e1368), daf-
7(e1372), and daf-9(dh6) animals scored on regu-
lar NGM plates at 25C under control (L4440) or
blmp-1-depleted conditions. In the latter geno-
types, blmp-1 depletion led to L3/L4 arrest without
dauer alae and SDS resistance. ***p < 0.001
(ANOVA). Mean + SEM (n = 3, 15 worms each).
(C) Representative DIC images of daf-2(e1368)
mutants grown on L4440 empty vector control
or blmp-1 RNAi at 25C for 48 hr. Arrowheads
indicate dauer alae. Scale bar, 10 mm.
(D) Lifespan analysis: WT animals were grown on
RNAi from the L4 stage as indicated. Dashed lines
represent an independent repeat of the experi-
ment. First, given p value (Mantel-Cox log rank
method) corresponds to the experiment displayed
with solid lines.
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DRE-1 Targets BLMP-1 for Degradationblmp-1mutant phenotype (Daf-d) prevailed in the double mutant
(Figure 4A). blmp-1 depletion also suppressed canonical Daf-c
loci, daf-2/InsR, daf-7/TGFb, and daf-9/CYP27A1 (Figures 4B
and 4C), placing blmp-1 downstream of insulin/IGF, TGFb, and
steroidal signaling at a late step in the dauer signaling pathways.
In addition blmp-1 and dre-1 affected organismal lifespan.
Knockdown of blmp-1 from L4 onward shortened wild-type
(WT) lifespan, similar to previous reports (Samuelson et al.,
2007), whereas dre-1 depletion resulted in a modest, but repro-
ducible, lifespan increase (Figure 4D). Therefore, the two genes
work in opposite ways for the life history traits of dauer formation
and longevity.
Just as blmp-1 loss suppressed dre-1 phenotypes, blmp-1
overexpression conversely further enhanced dre-1 phenotypes:
first, the blmp-1 overexpressor evoked strongly retarded
gonadal migration defects when grown on dre-1 RNAi (Fig-
ure S2A). Second, it enhancedmolting defects of dre-1-depleted
worms (Figures S2B and S2C). Third, it was synthetic lethal in a
dre-1(dh99) background, similar to dre-1 null mutants. In sum,
our genetic data reveal intimate genetic interaction between
dre-1 and blmp-1 for multiple processes.
The SCFDRE-1 Complex Degrades BLMP-1 via the
Proteasome
The genetic epistasis experiments described above place
blmp-1 downstream of dre-1, supporting the idea that
BLMP-1 could be a substrate of the SCFDRE-1 E3-ubiquitin
ligase. To directly test this hypothesis, we examined the effect
of dre-1 depletion on BLMP-1 protein levels. BLMP-1::GFP
showed overlapping expression with DRE-1::GFP in seam and
hypodermal cells as well as the dtcs (Figure S3A; data not
shown). Consistent with a role in BLMP-1 proteolysis, we found
that knockdown of dre-1 resulted in a striking 7- to 8-fold
increase in BLMP-1::GFP levels in seam and hypodermal cells
(Figures 5A and 5B). Knockdown of other SCF complex compo-
nents—the scaffold cul-1 and the skr-1 adaptor—also led to a702 Developmental Cell 28, 697–710, March 31, 2014 ª2014 Elseviersubstantial accumulation of BLMP-1::GFP, whereas knock-
down of related molecules (cul-4, skr-2, and -3) had little or
no effect (Figure 5B and S3B). In contrast, NHR-25::GFP
expression showed no obvious dre-1 dependence during
L2 to L4 larval stages (Figure S3C). To test whether the UPS
mediates BLMP-1 proteolysis, we inhibited the proteasome
using the synthetic inhibitor bortezomib or rpn-8 RNAi, which
depletes a subunit of the proteasomal 19S cap. Both treatments
significantly increased BLMP-1::GFP levels in seam and hypo-
dermis (Figures 5C, 5D, and S3B).
We next analyzed endogenous BLMP-1 levels bywestern blot-
ting using antibodies to visualize the native protein. In accordwith
our blmp-1::gfp transgene results, dre-1 loss of function and pro-
teasome inhibition by RNAi both resulted in a significant increase
in endogenous BLMP-1 protein (Figures 5E and 5F). Whereas
BLMP-1 levels were strongly elevated in a dre-1(dh99) mutant
background, blmp-1 mRNA levels were unchanged upon dre-1
depletionorproteasome inhibition (Figures5E–5G). These results
further support the notion that the SCFDRE-1 complex posttran-
scriptionally regulates BLMP-1 through proteasome-mediated
degradation.
If BLMP-1 were a direct substrate of DRE-1, then the two
proteins would be predicted to physically interact. Therefore,
we performed coimmunoprecipitation experiments in worms
expressing DRE-1::GFP under its native promoter. We found
that immunoprecipitation of DRE-1::GFP specifically coprecipi-
tated a small fraction of endogenous BLMP-1 (<1% of
input), whereas a NHR-25::GFP control did not (Figure 5H).
When expressed in HEK293T cells under proteasome inhibi-
tion FLAG-HA-tagged DRE-1 specifically coprecipitated with
6xHis-tagged C. elegans BLMP-1, but not the closely related
zinc-finger protein LIN-29 (Figure S3D). However, we could not
detect ubiquitylation of C. elegans BLMP-1 in our assays (data
not shown), but such species might be of low abundance or
unstable in vivo and difficult to ubiquitylate in a heterologous
system in vitro.Inc.
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Figure 5. DRE-1 Targets BLMP-1 for Proteasomal Degradation
(A) Representative DIC and fluorescence images of BLMP-1::GFP expressing L4 larvae grown on L4440 empty vector control or dre-1 RNAi.
(B) BLMP-1::GFP levels in seam and hypodermal cells are significantly increased upon dre-1 and cul-1 depletion. ***p < 0.001 (ANOVA). Mean + SEM (nR 3,R10
cells of five worms each).
(C) Representative DIC and fluorescence images of BLMP-1::GFP expressing L4 larvae treated with 100 mM bortezomib or DMSO control.
(D) Proteasome inhibition (bortezomib and rpn-8 RNAi) increases BLMP-1::GFP levels in seam and hypodermal cells. **p < 0.01, ***p < 0.001 (ANOVA). Mean +
SEM (nR 3,R10 cells of five worms each).
(E) Western blot analysis of endogenous BLMP-1 protein levels in WT, dre-1, and blmp-1 L4 larvae after various RNAi treatments from the egg stage and onward.
The asterisk marks a nonspecific band. The arrow points to the BLMP-1 band.
(F) Quantification of western blot analyses. *p < 0.05, **p < 0.01, ***p < 0.001 (ANOVA). Mean + SD (n = 5).
(G) qRT-PCR analysis of WT L4 larvae treated with the indicated RNAi from the egg stage. **p < 0.01 (ANOVA). Mean + SEM (n = 3).
(H) L3 larvae expressing integrated DRE-1::GFP or NHR-25::GFP as control were grown from the egg stage and onward on L4440 empty vector control or blmp-1
RNAi-expressing bacteria, respectively, and utilized for anti-GFP immunoprecipitation (IP). Lysates and IP were analyzed by immunoblotting. Detected sizes:
BLMP-1:z98 kDa, DRE-1::GFP:z145 kDa, and NHR-25::GFP:z120 kDa.
se, seam cell; hyp, hypodermal cell. Scale bars, 10 mm. See also Figures S2 and S3.
Developmental Cell
DRE-1 Targets BLMP-1 for Degradation
Developmental Cell 28, 697–710, March 31, 2014 ª2014 Elsevier Inc. 703
Developmental Cell
DRE-1 Targets BLMP-1 for DegradationThe DRE-1/BLMP-1 Interaction Is Conserved in
Mammals
Importantly, the association of BLMP-1 with DRE-1 is evolution-
arily conserved. First, like the worm proteins, human BLIMP-1
specifically coprecipitated with human FBXO11 when coex-
pressed in cultured HEK293T cells treated with proteasome in-
hibitor (Figures 6A and S4A). BLIMP-1 also weakly interacted
with the closely related FBXO10, but not with other controls (Fig-
ure 6A). Interestingly, the ability to bind BLIMP-1 was substan-
tially reduced when the Q491L amino acid substitution identified
in the Jeff mouse mutant (Hardisty-Hughes et al., 2006) was
introduced into human FBXO11, suggesting that the conserved
region containing the point mutation may facilitate interaction
(Figure 6A). Second, we found that immunopurified FBXO11 pro-
moted BLIMP-1 ubiquitylation in vitro, dependent upon a func-
tional F box domain, which tethers FBXO11 to the SCF complex:
F box domainmutation (F boxMUT/V98A, C99A, and F102A) abol-
ished binding to the SKP1 adaptor protein and consistently sup-
pressed ubiquitylated BLIMP-1 higher molecular weight species
(Figure 6B). Third, cycloheximide (CHX)-treated cells showed
progressive proteolysis of worm or human BLMP-1/BLIMP-1
upon cotransfection of DRE-1/FBXO11, which strongly de-
pended on a functional proteasome (Figures 6C and S4B). Rates
of human BLIMP-1 proteolysis were significantly dampened by
deletion of the FBXO11 F box domain (DF box) or by introducing
the amino acid substitution FBXO11/Q491L (Figure 6C). Further-
more, inclusion of a deletion mutant, dominant-negative form of
the SCF scaffold CUL1, but not other dominant-negative cullins,
prevented FBXO11-dependent BLIMP-1 degradation (Figures
S4C and S4D). In accord with a low BLIMP-1 binding affinity,
FBXO10 overexpression slightly destabilized BLIMP-1 after
CHX treatment (Figure 6C), indicating that FBXO10 might also
harbor a minor capability to target BLIMP-1. Finally, in agree-
ment with accelerated BLIMP-1 degradation, we found that
short hairpin RNA (shRNA)-mediated depletion of FBXO11
in ARP1 multiple myeloma cells using two different shRNAs
led to stabilization of endogenous BLIMP-1 in the presence of
CHX (Figure 6D). Altogether, these experiments demonstrate
that SCFFBXO11 mediates ubiquitin-mediated degradation of
BLIMP-1, providing strong evidence for conserved proteolytic
regulation across taxa.
BLMP-1 Is Dynamically Regulated in a Tissue-Specific
Manner
Having established BLMP-1 as a DRE-1 substrate for proteoly-
sis, we sought to better understand the dynamics of regulation
in vivo. The genetic studies in C. elegans described above reveal
that blmp-1 acts at an intermediate step in dtc migration but pro-
motes terminal differentiation in the hypodermis. To clarify the
tissue-specific regulation of developmental timing by DRE-1/
BLMP-1, we followed BLMP-1::GFP levels in these tissues
throughout larval development.
In the dtcs, BLMP-1::GFP was expressed from mid-L2, when
gonadal outgrowth initiates toward head and tail. By mid-L3
(28–30 hr developmental age [DA]), just prior to the dorsal
gonadal turn, BLMP-1::GFP levels in the dtcs dropped dramati-
cally (Figures 7A and 7B). Correlatively, DRE-1::GFP levels in the
dtcs increased steadily from L2 to L4 (Figure S5A). In contrast,
when worms were grown on dre-1 RNAi, BLMP-1::GFP levels704 Developmental Cell 28, 697–710, March 31, 2014 ª2014 Elsevierpersisted to later ages and the dtcs frequently failed to turn
dorsally (Figures 7A, 7B, and S2A). Our data therefore strongly
suggest that timely DRE-1-mediated BLMP-1 degradation per-
mits the gonadal turn, whereas high BLMP-1 levels in gonadal
dtcs impede this event (Figure 7D).
Surprisingly, in seam and hypodermal cells BLMP-1::GFP
levels were largely constant throughout larval development,
except for a transient peak early in L4, which coincides with
the time of seam cell fusion (Figure 7C), suggesting this BLMP-
1 pulse could trigger the fusion event. Consistent with this,
dre-1 knockdown provoked a strong increase of seam and
hypodermal BLMP-1::GFP expression earlier in development
(Figure 7C), resulting in seam fusion as early as 28 hr of DA during
the L3 stage. These observations are consistent with a model in
which increased BLMP-1 levels initiate terminal differentiation
events in the seams (Figure 7E). Unexpectedly, DRE-1::GFP
levels in seam and hypodermis did not obviously change during
this time (Figure S5B), implying that other instructive compo-
nents or cofactors (e.g., a kinase or phosphatase) may contribute
toward BLMP-1 regulation. Altogether, our data suggest that
DRE-1 maintains a low steady-state level of BLMP-1 to prevent
precocious terminal differentiation in the epidermis (Figure 7E).
blmp-1 Expression Profiles
To identify downstream effectors regulated by the transcription
factor blmp-1, we performed RNA sequencing (RNA-seq) anal-
ysis of blmp-1 mutant and WT animals harvested at the mid-
L3 stage. We identified 325 significantly upregulated genes
and 303 downregulated genes (R1.5-fold difference from WT,
q value < 0.05) (Table S2). Differentially regulated genes included
those enriched in the biological processes of molting and cuticle
development, sugar and aminosugar metabolism, and protein
modification (Figure 7F). The molting and cuticle-related regu-
lated genes included ptr-8, wrt-2, bed-3, nas-36, and collagens
(e.g., col-7, col-91, and col-124). blmp-1-dependent regulation
of these genes was further confirmed by qRT-PCR in L3 larvae
and young adult animals (Figure 7G). These data support the
idea that blmp-1 is a key regulator ofC. elegans epidermal termi-
nal differentiation.
DISCUSSION
In this study we discovered that the highly conserved
SCFDRE-1/FBXO11 E3-ubiquitin ligase complex targets the zinc-
finger transcriptional repressor BLMP-1 as a substrate. DRE-1
and BLMP-1 work as a functional module to regulate not only
C. elegans developmental timing but also the processes of dauer
formation, molting, and longevity, revealing a global role in life
history regulation. Remarkably, we find the DRE-1/BLMP-1 mo-
lecular interaction to be conserved in human cells, suggesting
that FBXO11 and BLIMP-1 could act together to regulate related
processes in mammals.
Multiple lines of evidence argue that BLMP-1/BLIMP-1 is
an endogenous substrate degraded by the SCFDRE-1/FBXO11
complex. First, BLMP-1 and DRE-1 coimmunoprecipitate in vivo
from C. elegans, and, when expressed in cell culture, so do the
human counterparts. Second,mammalian FBXO11 ubiquitylates
BLIMP-1 in vitro. Third, BLMP-1 protein levels strikingly depend
on the SCFDRE-1 complex and the proteasome. Loss of DRE-1Inc.
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Figure 6. FBXO11 Directly Interacts with BLIMP-1 and Triggers Its Degradation
(A) Anti-FLAG IP of human FLAG-HA-tagged (F/H) RFP, -FBXO5, -FBXO10, -FBXO11, and -FBXO11(Q491L/Jeff) from HEK293T cells treated with 15 mMMG132.
Human His-BLIMP-1 was coexpressed. See (C) for detected protein sizes. Quantification of RFP/F box-protein binding intensity to BLIMP-1 was normalized to
BLIMP-1 input and FBXO11-BLIMP-1 association. ***p < 0.001 (ANOVA). Mean + SD (n = 5). nd, not detectable.
(B) HEK293T cells were transfected with His-tagged BLIMP-1, FLAG-tagged FBXO11, or -FBXO11(F boxMUT) and an empty vector as indicated. After
immunopurification with anti-FLAG resin, in vitro ubiquitylation of BLIMP-1 was performed in the presence of E1 and E2s. Where indicated, ubiquitin was added.
Samples were analyzed by immunoblotting (left panel). Immunoblots of whole-cell extracts and immunoprecipitations are shown in the right panel. Detected size
of SKP1 isz19 kDA; the other proteins are as indicated in (C) and (D).
(C) Human BLIMP-1 stability was assessed in HEK293T cells transfected with His-BLIMP-1 and -RFP in combination with either F/H-tagged
RFP, -FBXO11, -FBXO11 (DF box), -FBXO11(Q491L /Jeff), -FBXO5, or -FBXO10.Cellswere treatedwith cycloheximide (CHX) or CHX± 15 mMMG132 for 0, 1, 2, or
4 hr prior to harvesting andanalysisby immunoblotting. HumanBLIMP-1 stabilitywasquantified fromR3 independent experiments andnormalized to coexpressed
His-RFP. Mean + SD (nR 3).
(D) Stability of endogenous BLIMP-1 was analyzed in ARP1 multiple myeloma cells infected with either viruses expressing two different FBXO11 shRNAs or an
empty virus (CTRL) and selected for 72 hr. Cells were then treated with CHX for the indicated times, and protein extracts were analyzed by immunoblotting. The
following sizes were detected: BLIMP-1z90 kDA and FBXO11z125 kDA.
See also Figure S4.
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Figure 7. BLMP-1::GFP Levels Are Dynamically Regulated by DRE-1
(A) BLMP-1::GFP levels in the dtcs were assessed inR5 worms per grouped DA (developmental age). ***p < 0.001 (ANOVA). Mean + SD.
(B) Representative DIC images of age-matched L3 larvae, with zoom in on BLMP-1::GFP expression in the dtcs. Black box indicates the area enlarged in the
fluorescence image. White circle roughly marks the dtc nucleus. Scale bars, 10 mm.
(C) BLMP-1::GFP levels in seam and hypodermal cells were assessed inR5 worms per grouped DA. *p < 0.05 (ANOVA). Mean + SEM.
(D) Model for dre-1/blmp-1 action in gonadal tissue: BLMP-1 is downregulated in a dre-1-dependent manner in mid-L3 to allow the dorsal gonadal turn. In
dre-1 or dre-1/daf-12 mutants BLMP-1 levels persist to later ages, leading to retarded migration defects, whereas the dorsal turn is preceded in the absence
of BLMP-1.
(E) Somatic tissue: elevated BLMP-1 levels contribute to seam cell terminal differentiation, leading to precocious terminal differentiation in dre-1 mutants and
consequentially impaired terminal differentiation in the absence of BLMP-1. Double slashes indicate the end of data assessment.
(F) Summary of gene ontology (GO)/biological processes derived from DAVID analysis (Huang et al., 2009) of differentially regulated genes (q < 0.05, fold
change > ±1.5) in WT versus blmp-1mutant animals from RNA sequencing data sets (n = 3). ReviGO was used for visualizing the resulting GO term classes and
their semantic similarities (Supek et al., 2011). Bubble color, size, and line widths, respectively, indicate significance of enrichment, frequency of GO term in
underlying data sets, and degree of similarity. More intense colors indicate a higher significance of enrichment.
(G) qRT-PCR analysis of blmp-1-regulatedmolting and cuticle-related genes in L3 larvae and young adult worms. *p < 0.05, **p < 0.01, ***p < 0.001 (t test). Mean +
SEM (nR 3).
See also Figure S5.
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DRE-1 Targets BLMP-1 for Degradationand other components of the SCF complex, as well as pro-
teasome inhibition, result in elevated endogenous BLMP-1 or
BLMP-1::GFP levels in C. elegans. Conversely, DRE-1 over-
expression in cell culture enhances BLMP-1 degradation. This
molecular function is conserved because mammalian FBXO11
degrades BLIMP-1 when expressed in cultured cells and
shRNA-mediated depletion of FBOX11 in the ARP1 multiple
myeloma cell line leads to stabilization of endogenous BLIMP-1.
Finally, blmp-1 depletion strongly suppresses dre-1 het-
erochronic phenotypes in seam and gonadal tissue. This strict
epistasis indicates that dre-1 acts through blmp-1 in a regulatory
pathway and suggest that dre-1 phenotypes arise largely from
elevated BLMP-1 activity. In accord with this, blmp-1 overex-
pression exacerbates dre-1 phenotypes. Taken together, our re-
sults demonstrate that BLMP-1 is a substrate of the SCFDRE-1
complex and that this molecular activity is evolutionarily
conserved. This study therefore provides critical evidence for
BLMP-1/BLIMP-1 being specifically targeted for proteasomal
degradation.
DRE-1 and BLMP-1 work as a module to regulate several as-
pects ofC. elegans life history. In particular, our studies establish
dre-1/blmp-1 as key regulators of developmental timing within
the heterochronic circuit during late larval development. Our
previous work demonstrated that dre-1 loss of function induces
precocious seam cell fusion and synthetic retarded gonadal
migration defects. Here, we discovered blmp-1 depletion to effi-
ciently suppress both phenotypes. On its own, blmp-1 mutation
leads to phenotypes opposite to dre-1, namely, retarded termi-
nal differentiation of the seam cells (e.g., poor alae formation),
on the one hand, and precocious migration of gonadal dtcs, on
the other hand. These findings imply that blmp-1 like its mamma-
lian counterpart mediates terminal differentiation in some tissues
but also controls intermediate stages of differentiation in others,
presumably by regulating distinct targets. Importantly, blmp-1
genetically interacts with multiple heterochronic loci that govern
the larval-to-adult transition. blmp-1 loss of function enhances
retarded (let-7, mab-10/NAB) and suppresses precocious
(lin-41/Trim71, lin-42/Period, hbl-1/Hunchback, and sop-2/
PolycombG-like) heterochronic mutants for phenotypes in the
epidermal seam cells. These interactions firmly place blmp-1
within the heterochronic circuit controlling late larval develop-
ment. Understanding how these genetic interactions translate
into molecular regulatory events should be interesting to dissect
in the future.
Many of the C. elegans heterochronic genes governing seam
cell development have counterparts in mammals regulating
skin stem cell homeostasis, including blmp-1/BLIMP-1 itself,
daf-12/FXR/VDR, lin-4/mir-125, let-7, lin-42/Period, and others
(Cianferotti et al., 2007; Horsley et al., 2006; Janich et al.,
2011; Magnu´sdo´ttir et al., 2007; Zhang et al., 2011). In particular,
BLIMP-1 is required for terminal differentiation of the skin spec-
ifying the transition from granule to cornified layers in keratino-
cytes and stem cell lineages in the sebaceous gland (Horsley
et al., 2006; Magnu´sdo´ttir et al., 2007). Therein, BLIMP-1 and
the vitamin D receptor were shown to be downregulated by
mir-125 to prevent skin stem cell differentiation (Zhang et al.,
2011). Our data show that C. elegans blmp-1 specifies terminal
differentiation in the epidermis and indicate that this regulation
could stem from blmp-1-dependent transcriptional changes inDevelomolting and cuticle synthesis genes. Moreover, dauer epistasis
analyses place blmp-1 at a late step in dauer morphogenesis
pathways proximal to daf-12/FXR/VDR, bearing remarkable
similarity to the mammalian situation in the skin. Interestingly,
FBXO11 too is expressed in the skin (Hardisty-Hughes et al.,
2006), suggesting a possible role for FBXO11 in BLIMP-1-
dependent regulation of skin maturation.
Our studies also reveal that DRE-1/BLMP-1 affect organism-
wide fates, including the entry into the dauer diapause, molting,
and adult longevity. Moreover, dre-1 was shown to function in
male gonadal linker cell engulfment and blmp-1 in male tail
retraction (Chiorazzi et al., 2013; Nelson et al., 2011). Although
much is known about vertebrate BLIMP-1, the rich signaling
circuits presiding over C. elegans developmental timing, dauer
signaling, molting, and lifespan might further inform mammalian
stem cell progression and quiescence. In this view, it could be
argued that the FBXO11/BLIMP-1 module not only acts as fate
switch regulating cellular differentiation but also perhaps more
broadly functions as part of a developmental timer across tis-
sues and species.
Indeed, the notion that DRE-1/BLMP-1 comprise a conserved
functional module may have several implications in mammals.
Among other things, BLIMP-1 is a key regulator in primordial
germ cell specification (Ohinata et al., 2005, 2009; Vincent
et al., 2005), forelimb development, pharyngeal and heart
morphogenesis (Vincent et al., 2005), T cell differentiation (Mar-
tins and Calame, 2008), pluripotency, and reprogramming
(Nagamatsu et al., 2011). By inference, FBXO11 could work
in tandem with BLIMP-1 in at least some of these contexts by
controlling its turnover.
Despite its high conservation, relatively little is known about
the biological function of mammalian FBXO11. Its loss of func-
tion is associated with chronic otitis media, facial clefting, and
other developmental abnormalities (Hardisty et al., 2003; Har-
disty-Hughes et al., 2006; Segade et al., 2006). Our studies
suggest these phenotypes could in some measure result from
aberrantly elevated BLIMP-1 levels, because FBXO11-depen-
dent BLIMP-1 degradation is significantly impaired by intro-
ducing the FBXO11 Jeff mutation, which affects a highly
conserved residue. FBXO11 is also known to play a critical
role in tumorigenesis in the immune system. Duan et al. (2012)
recently showed FBXO11 to target BCL6 for proteasomal
degradation and FBXO11 inactivation results in aberrantly
elevated BCL6 levels in diffuse large B cell lymphomas. Zinc-
finger proteins BLIMP-1 and BCL6 are reciprocally antagonistic
transcription factors that serve as a self-reinforcing switch to
determine B- and T- cell fates (Crotty et al., 2010). Specifically,
BLIMP-1 promotes terminal differentiation of B-plasma cells,
whereas BCL6 functions in the maintenance of germinal center
B cells. Blimp-1 inactivation is also associated with the onset
of B Cell-like diffuse large B cell lymphomas (Mandelbaum
et al., 2010). Intriguingly, FBXO11 thus targets both BLIMP-1
(this work) and BCL6 for proteolytic degradation, but how their
regulation is coordinated within normal immune lineages and
in tumorigenesis is not yet understood. The closely related
FBXO10 has also been implicated in degrading BCL2 (Chiorazzi
et al., 2013), suggesting a general role for FBXO10/11 com-
plexes in immune function. It is noteworthy that immune devel-
opment, too, employs many homologs of developmental timingpmental Cell 28, 697–710, March 31, 2014 ª2014 Elsevier Inc. 707
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et al., 2010; Yuan et al., 2012).
Taken together, we discovered BLMP-1 as a substrate of the
SCFDRE-1 complex, modulating developmental timing, and other
life history traits in C. elegans. Given the remarkable degree of
structural and functional conservation of these two proteins,
we hypothesize that the FBXO11/BLIMP-1 module could regu-
late metazoan cellular fate decisions across tissues.
EXPERIMENTAL PROCEDURES
C. elegans Strains, RNAi, and Treatments
C. elegans strains were grown under standard conditions at 20C unless other-
wise noted (Brenner, 1974). Strains used are listed in the Supplemental Exper-
imental Procedures. RNAi treatment was performed as described (Kamath
and Ahringer, 2003). In general, L4 larvae were moved to corresponding
RNAi plates. RNAi clones were available from the Ahringer collection, except
for dre-1 RNAi, which we described previously (Fielenbach et al., 2007). Pro-
teasome inhibition was achieved by transferring L3 larvae to a plate containing
100 mM bortezomib (in DMSO) on top of the bacteria lawn, for 6 hr.
Microscopy and Phenotype Analysis
Heterochronic phenotypes were analyzed at specific larval stages as as-
sessed by gonad morphology and vulva formation. Nomarski differential
interference contrast (DIC) microscopy was used to score seam cell number
(scm-1::gfp marker), seam cell fusion (ajm-1::gfp marker), and adult alae for-
mation, each on one side of individual animals. Worms were anesthetized
with 1 mM levamisole. Fluorescence microscopy was performed on a Carl
Zeiss Axio Imager Z1. GFP intensity in seam/hypodermal cells was leveled
from 5–10 cells per animal, whereas for measurements in the dtc, one dtc
per animal was analyzed. Fluorescence intensity was determined using the
ImageJ software (http://rsbweb.nih.gov/ij/).
Dauer and Lifespan Analysis
For dauer assays worms were synchronized by egg-lay on OP50 or HT115
bacteria and scored after 48 hr (27C) or 60 hr (25C). Lifespan assays were
performed at 20C. Worms were synchronized by egg-lay and transferred to
RNAi plates at the L4 stage. Worms undergoing internal hatching, bursting
vulva, or crawling off the plates were censored.
Antibodies
The following antibodies were used in this study: BLMP-1 (rb, Novus Bio), GFP
(ms, Clontech), a-tubulin (ms, Sigma), HA (rat, Roche), His (ms, QIAGEN;
rb, Santa Cruz), FLAG (ms and rb, SIGMA), PCNA (ms, Invitrogen), BLIMP-1
(rb, ab59369, Abcam; ms, 3H2-E8, Novus Bio), FBXO11 (rb, NB100-59826,
Novus Bio), and SKP1 (Pagano lab).
C. elegans Biochemistry
For the western blot analysis, synchronized L4 larvae were lysed in SDS sam-
ple buffer, and equal volumes were applied to SDS-PAGE and immunblotting.
Band intensity was quantified with Adobe Photoshop.
For immunoprecipitation (IP) assays, eggs were isolated by bleach treat-
ment. After a 3 hr hatching period, L1 larvae were washed off with M9 buffer
and transferred to RNAi plates. L3 larvae were lysed in worm IP buffer
(50 mM Tris/HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, 0.1% NP-40, protease
and phosphatase inhibitor cocktail [Roche]) using a dounce homogenizer.
Worm lysates were incubated with 40 ml GFP-Trap agarose beads (Chromo-
tek) for 1 hr at 4C and washed five times with worm washing buffer (same
as worm IP buffer, but with 300 mM NaCl and 0.75% NP-40). Precipitants
were eluted with SDS sample buffer and analyzed by SDS-PAGE and
immunoblotting.
Cell Culture and IP Experiments
HEK293T cells were maintained in Dulbecco’s modified Eagle’s medium,
supplemented with 10% fetal bovine serum (GIBCO). Transfections were
performed using Lipofectamine 2000 (Invitrogen) in accordance with the708 Developmental Cell 28, 697–710, March 31, 2014 ª2014 Elseviermanufacturer’s instruction. Plasmid construction is described in the Supple-
mental Experimental Procedures. For IP experiments (not prior to ubiquitylation
assay), cells were treated with 15 mM MG132 or DMSO control for 4 hr prior
to harvesting. Cells were lysed 20 hr posttransfection in lysis buffer (50 mM
Tris/HCl [pH 7.4], 120 mM NaCl, 0.5% NP-40, protease and phosphatase in-
hibitor cocktail [Roche]) and subsequently incubated with anti-FLAG-M2
resin (Sigma). Precipitated proteins were eluted by competition with 3xFLAG
peptide (Sigma) and analyzed by immunoblotting. To study BLIMP-1 turnover,
transfected cells were treated with 100 mg/ml cycloheximide (AppliChem) for
the indicated time intervals 20 hr posttransfection. Cells were lysed in lysis
buffer and analyzed by SDS-PAGE and immunoblotting. Whole-cell lysates
and CHX treatment in ARP1 cells was performed as described (Duan et al.,
2012).
Gene Silencing by shRNAs
Sequences of FBXO11 shRNAs were as follows: (1) GAGTTTACATCTTT
GGTGA and (2) CAATTGTTCGGCATAACAA. shRNA lentiviruses were pro-
duced as described (Phan et al., 2007). ARP1 multiple myeloma cells were in-
fected by resuspension in virus-containing supernatants and centrifugation.
Twenty-four hours after infection, cells were resuspended in fresh medium
and selected with puromycin.
In Vitro Ubiquitylation
HEK293T cells were cotransfected with His-BLIMP-1 and FLAG-FBXO11
or -FBXO11(F boxMUT) and lysed using isotonic NP40 buffer with Turbo-
nuclease (Accelagen). Lysates were precleared with 0.40 mm filters and
FLAG-tagged complexes were isolated using anti-FLAG-M2 resin (Sigma).
Complexes were eluted by competition with 3xFLAG peptide (Sigma).
In vitro ubiquitylation assays were performed in a volume of 30 ml containing
0.1 mM UBE1 (Boston Biochem), 10 ng/ml Ubch3, 10 ng/ml Ubch5c, 1 mM
ubiquitin aldehyde, ±2.5 mg/ml ubiquitin (Sigma), and either SCFFBXO11 or
SCFFBXO11F box-MUT complex in a ubiquitylation buffer (50 mM Tris [pH 7.6],
2 mM ATP, 5 mM MgCl2, 0.6 mM DTT, and okadaic acid 0.1 mM) for 45 min
at 37C.
Statistical Analysis
Statistical analyses were performed as indicated using GraphPad Prism
(GraphPad software).
ACCESSION NUMBERS
The Gene Expression Omnibus NCBI accession number for the RNA-seq data
of WT and blmp-1 mutant L3 larvae reported in this paper is GSE55225.
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